Published in Mol Neurobiol on November 23, 2016
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol (1989) 37.83
METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics (2010) 21.21
Annotation of functional variation in personal genomes using RegulomeDB. Genome Res (2012) 11.47
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Identifying autism loci and genes by tracing recent shared ancestry. Science (2008) 7.72
The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology (2005) 5.64
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet (2014) 4.60
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56
Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol (2004) 3.79
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Transformations, means, and confidence intervals. BMJ (1996) 3.42
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J Clin Oncol (2011) 3.33
Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am J Hum Genet (2011) 3.21
Fetuin-A and incident diabetes mellitus in older persons. JAMA (2008) 2.92
Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope (1996) 2.78
Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol (2008) 2.73
Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat Methods (2013) 2.71
Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg (1991) 2.34
Different noses for different people. Nat Genet (2003) 2.10
The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc Natl Acad Sci U S A (2007) 2.01
Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology (2010) 1.86
Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc Natl Acad Sci U S A (2009) 1.73
Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol (2001) 1.69
The genetics and neuropathology of Alzheimer's disease. Acta Neuropathol (2012) 1.56
On the scent of human olfactory orbitofrontal cortex: meta-analysis and comparison to non-human primates. Brain Res Brain Res Rev (2005) 1.49
Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci (2009) 1.49
KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin. Mol Cell Biol (2009) 1.44
Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer`s disease. A meta-analysis. Neurosciences (Riyadh) (2012) 1.17
Olfactory dysfunction predicts 5-year mortality in older adults. PLoS One (2014) 1.13
Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies. Mov Disord (2006) 1.08
Diagnosis and assessment of Alzheimer's disease in diverse populations. Alzheimers Dement (2008) 1.07
The human gamma-aminobutyric acid A receptor delta (GABRD) gene: molecular characterisation and tissue-specific expression. Gene (2002) 1.06
Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull (2013) 1.04
Olfactory cilia: linking sensory cilia function and human disease. Chem Senses (2009) 1.04
Odor identification and mortality in old age. Chem Senses (2010) 1.03
Racial disparities in olfactory loss among older adults in the United States. J Gerontol A Biol Sci Med Sci (2013) 0.94
LRRK2 expression is enriched in the striosomal compartment of mouse striatum. Neurobiol Dis (2012) 0.90
Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiol Aging (2008) 0.90
Olfaction in the autism spectrum. Perception (2013) 0.87
Cdk5-mediated phosphorylation of RapGEF2 controls neuronal migration in the developing cerebral cortex. Nat Commun (2014) 0.87
Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord. Brain Res (2008) 0.86
Olfaction: anatomy, physiology, and disease. Clin Anat (2013) 0.86
Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels. Hum Mol Genet (2012) 0.83
Olfactory function and schizophrenia: an update. Curr Opin Psychiatry (2010) 0.82
Fast association tests for genes with FAST. PLoS One (2013) 0.82
Follistatin-like 5 is expressed in restricted areas of the adult mouse brain: Implications for its function in the olfactory system. Congenit Anom (Kyoto) (2014) 0.80
Induction of KLF4 contributes to the neurotoxicity of MPP + in M17 cells: a new implication in Parkinson's disease. J Mol Neurosci (2013) 0.76
Olfactory abnormalities in temporal lobe epilepsy. J Clin Neurosci (2015) 0.76
Genome-wide methylation profiling of schizophrenia. Balkan J Med Genet (2015) 0.75
Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults. Medicine (Baltimore) (2015) 0.75
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet (2014) 3.94
Emotional neglect in childhood and cerebral infarction in older age. Neurology (2012) 1.50
Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet (2015) 1.05
At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement (2014) 1.02
Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans. Alzheimers Dement (2014) 0.90
CHCHD2 and Parkinson's disease. Lancet Neurol (2015) 0.87
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides. EMBO Mol Med (2016) 0.87
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. Alzheimers Dement (2016) 0.86
Genetic variants in RBFOX3 are associated with sleep latency. Eur J Hum Genet (2016) 0.82
Whole-exome imputation of sequence variants identified two novel alleles associated with adult body height in African Americans. Hum Mol Genet (2014) 0.81
DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol (2016) 0.79
Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population. Neurobiol Aging (2016) 0.78
Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families. Neurobiol Aging (2015) 0.78
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data. Lancet Neurol (2016) 0.77
Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains. Mol Neurobiol (2015) 0.77
Atrial Fibrillation, Cognitive Decline And Dementia. Eur Cardiol (2016) 0.77
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing. Genome Biol (2017) 0.77
Rest-activity patterns and falls and fractures in older men. Osteoporos Int (2016) 0.77
GWAS analysis of handgrip and lower body strength in older adults in the CHARGE consortium. Aging Cell (2016) 0.76
Additional Rare Variant Analysis in Parkinson's Disease Cases with and Without Known Pathogenic Mutations: Evidence for Oligogenic Inheritance. Hum Mol Genet (2016) 0.76
A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression. Alzheimers Dement (2016) 0.75
Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study. Alzheimers Dement (Amst) (2016) 0.75
Fine-mapping, novel loci identification, and SNP association transferability in a genome-wide association study of QRS duration in African Americans. Hum Mol Genet (2016) 0.75
Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment. Acta Neuropathol Commun (2016) 0.75
Dietary determinants of cadmium exposure in the Strong Heart Family Study. Food Chem Toxicol (2016) 0.75
The appropriate use of risk scores in the prediction of atrial fibrillation. J Thorac Dis (2016) 0.75
The Birth of the Modern Era of Parkinson's Disease Genetics. J Parkinsons Dis (2017) 0.75
Gene-gene Interaction Analyses for Atrial Fibrillation. Sci Rep (2016) 0.75
The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol (2016) 0.75
Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218. Transl Psychiatry (2020) 0.75
Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium. Sci Rep (2017) 0.75
Peripheral serum metabolomic profiles inform central cognitive impairment. Sci Rep (2020) 0.75
Association between excessive daytime sleepiness and measures of supraventricular arrhythmia burden: evidence from the Atherosclerosis Risk in Communities (ARIC) study. Sleep Breath (2020) 0.75
Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol (2017) 0.75
Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia. J Alzheimers Dis (2018) 0.75
Establishing the role of rare coding variants in known Parkinson's disease risk loci. Neurobiol Aging (2017) 0.75
Association of midlife lipids with 20-year cognitive change: A cohort study. Alzheimers Dement (2017) 0.75
Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study. Alzheimers Dement (2017) 0.75
Brain function and structure and risk for incident diabetes: The Atherosclerosis Risk in Communities Study. Alzheimers Dement (2017) 0.75
Sex hormones and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA). Endocrine (2017) 0.75
Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis (2016) 0.75
Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease. J Neuropathol Exp Neurol (2017) 0.75
Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener (2017) 0.75
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord (2017) 0.75
Sigmoidal mixed models for longitudinal data. Stat Methods Med Res (2016) 0.75
Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement (2016) 0.75
β-Thromboglobulin and incident cardiovascular disease risk: The Atherosclerosis Risk in Communities study. Thromb Res (2017) 0.75
The Ability of a Single BMD and Fracture History Assessment to Predict Fracture Over 25 Years in Postmenopausal Women: The Study of Osteoporotic Fractures. J Bone Miner Res (2017) 0.75
Single-cell dissection of the human brain vasculature. Nature (2022) 0.75
Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain (2020) 0.75